Skip to main content

Table 1 Serum immunoglobulin concentration in Algerian patients

From: Clinical, immunological and genetic features in eleven Algerian patients with major histocompatibility complex class II expression deficiency

 

Age at diagnosis M: months; Y: year

Serum Ig concentration (g/l)

  

IgG

IgM

IgA

1

10 y

6.21 (6.55–12.17)

0.34 (0.62–1.77)

0.06 (0.49–1.57)

2

2 y 6 m

4.85 (7.10–10.70)

0.41 (0.48–0.78)

0.24 (0.66–1.20)

3

4 y

4.83 (7–11.60)

1.03 (0.40–0.90)

0.67 (0.79–1.69)

4

2 m

0.93 (2–6)

0.26 (0.12–0.48)

0.25 (0.08–0.34)

5

1 y 10 m

1.63 (5.60–9.60)

0.18 (0.35–0.81)

0.24 (0.26–0.74)

6

4 y

4.77 (7–11.60)

0.73 (0.40–0.90)

0.59 (0.79–1.69)

7

2 y 3 m

10 (5.60–9.60)

1.18 (0.35–0.81)

0.75 (0.26–0.74)

8

4 y

19.10 (7–11.60)

1.42 (0.04–0.90)

2.29 (0.79–1.69)

9

1 y 10 m

6.82 (7–10.60)

0.63 (0.79–1)

1.82 (0.66–1.2)

10

6 y

4.79 (6.8–11.8)

ND

0.07 (0.32–0.98)

11

4 y

4.57 (7–11.60)

0.25 (0.04–0.90)

0.23 (0.79–1.69)

  1. (ND: not determined; normal values for age are given between brackets).